Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children

Medical Science Monitor

Volumn 16, Issue 4, 2010, Pages

  Zaffanello, Marco ^a   Cataldi, Luigi ^b   Franchini, Massimo ^c   Fanos, Vassilios ^d  

^a UNIVERSITY OF VERONA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Children; Post streptococcal glomerulonephritis; Prevention; Randomized controlled trial; Treatment

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CEFTIBUTEN; CEFUROXIME; CEPHALOSPORIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; DIURETIC AGENT; ENALAPRIL; ERYTHROMYCIN; FUROSEMIDE; HEPARIN; LORACARBEF; NIFEDIPINE; PENICILLIN V; PREDNISONE; RESERPINE; VASODILATOR AGENT; WARFARIN; ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

ACUTE POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; ADOLESCENT; ADULT; BLOOD PRESSURE REGULATION; CHILD; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DISEASE CONTROL; DISEASE COURSE; DRUG USE; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; INFANT; KIDNEY BIOPSY; LONG TERM CARE; PRESCHOOL CHILD; PROGNOSIS; REVIEW; SCHOOL CHILD; STREPTOCOCCUS INFECTION; THERAPY EFFECT; BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; NEWBORN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFECTIVE AGENTS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; GLOMERULONEPHRITIS; GUIDELINES AS TOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; OUTCOME ASSESSMENT (HEALTH CARE); STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 77954279957     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Williams DG: C3 nephritic factor and mesangiocapillary glomerulonephritis. Pediatr. Nephrol, 1997; 11: 96-98
2. Blyth CC, Robertson PW, Rosenberg AR: Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review. J Paediatr Child Health, 2007; 43: 446-50
3. Berríos X, Lagomarsino E, Solar E et al: Post-streptococcal acute glomerulonephritis in Chile-20 years of experience. Pediatr Nephrol, 2004; 19: 306-12
4. Muscatello DJ, O'Grady KA, Neville K, McAnulty J: Acute poststreptococcal glomerulonephritis: public health implications of recent clusters in New South Wales and epidemiology of hospital admissions. Epidemiol Infect, 2001; 126: 365-72
5. Kanjanabuch T, Kittikowit W, Eiam-Ong S: An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol, 2009; 5: 259-69
6. Coppo R, Gianoglio B, Porcellini MG, Maringhini S: Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology. Nephrol Dial Transplant, 1998; 13: 293-97
7. Ilyas M, Tolaymat A: Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol, 2008; 23: 1101-6
8. Rodriguez-Iturbe B: Postinfectious glomerulonephritis. Am J Kidney Dis, 2000; 35: XLVI-XLVIII
9. Carapetis JR, Steer AC, Mulholland EK, Weber M: The global burden of group A streptococcal diseases. Lancet Infect Dis, 2005; 5: 685-94
10. Wong W, Morris MC, Zwi J: Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children. Pediatr Nephrol, 2009; 24: 1021-26
11. Rodriguez-Iturbe B, Musser JM: The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol, 2008; 19: 1855-64
12. Pais PJ, Kump T, Greenbaum LA: Delay in diagnosis in poststreptococcal glomerulonephritis. J Pediatr, 2008; 153: 560-64
13. Nordstrand A, Norgren M, Holm SE: Pathogenic mechanism of acute post-streptococcal glomerulonephritis. Scand J Infect Dis, 1999; 31: 523-37
14. Adam D, Scholz H, Helmerking M: Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis. J Antimicrob Chemother, 2000; 45: 23-30
15. Adam D, Scholz H, Helmerking M: Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis. Fortschritte der Medizin, 2001; 119: 63-70
16. Adam D, Scholz H, Helmerking M: Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae. J Infect Dis, 2000; 182: 509-16
17. Scholz H: Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age. Chemotherapy, 2004; 50: 51-54
18. Ribeiro NJPM, Toporovski J: Nifedipine versus placebo in the treatment of hypertension in children with post-streptococcal glomerulonephritis. Jornal de Pediatrie, 1992; 68: 283-88
19. Morsi MR, Madina EH, Anglo AA, Soliman AT: Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis. Acta Paediatr, 1992; 81: 145-49
20. Jankauskiene A, Cerniauskiene V, Jakutovic M, Malikenas A: Enalapril influence on blood pressure and echocardiographic parameters in children with acute post-infectious glomerulonephritis. Medicina (Kaunas), 2005; 41: 1019-25
21. Roy S III, Murphy WM, Arant BS Jr: Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care. J Pediatr, 1981; 98: 403-10
22. Tanphaichitr P: Oral furosemide versus conventional therapy for acute poststreptococcal glomerulonephritis in children. J Med Assoc Thai, 1977; 60: 213-17
23. Sólomon-Santibañez G, Vargas-Rosendo R, Santos-Atherton D: Efficacy of intravenous furosemide in the initial stage of poststreptococcal acute glomerulonephritis. Arch Invest Med (Mex), 1971; 2: 115-20
24. Powell HR, McCredie DA, Rotenberg E: Response to frusemide in acute renal failure: dissociation of renin and diuretic responses. Clin Nephrol, 1980; 14: 55-59
25. Faye O, Hay RJ, Diawara I, Mahé A: Oral amoxicillin vs. oral erythromycin in the treatment of pyoderma in Bamako, Mali: an open randomized trial. Int J Dermatol, 2007; 46: 19-22
26. Lord RW Jr: Is a 5-day course of antibiotics as effective as a 10-day course for the treatment of streptococcal pharyngitis and the prevention of poststreptococcal sequelae? J Fam Pract, 2000; 49: 1147
27. Sarkissian A, Papazian M, Azatian G et al: An epidemic of acute postinfectious glomerulonephritis in Armenia. Arch Dis Child, 1997; 77: 342-44
28. El-Husseini AA, Sheashaa HA, Sabry AA et al: Acute postinfectious crescentic glomerulonephritis: clinicopathologic presentation and risk factors. Int Urol Nephrol, 2005; 37: 603-9
29. Zaffanello M, Fedrizzi M: Delayed diagnosis of post-streptococcal glomerulonephritis. J Pediatr, 2009; 154: 777
30. Zaffanello M, Franchini M, Fanos V: New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy. Pharmacotherapy, 2008; 28: 125-30
31. Wong W, Morris MC, Zwi J: Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children. Pediatr Nephrol, 2009; 24: 1021-26